Treatments for Benign Paroxysmal Positional Vertigo (BPPV)

July 25, 2012 updated by: Helen Cohen, Baylor College of Medicine
The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, the Brandt-Daroff exercises and nonspecific vestibular habituation exercises. These procedures involve exercises and head manipulations. Vertigo intensity and frequency, the presence/absence of slow-phase eye movements, the degree of dizziness handicap and acts of daily living (ADL) were assessed. The study also ascertained the effects of co-morbid conditions on the response to treatment. While BPPV is a common and significant public health problem that has been recognized for several decades, this is the first systematic study of the relative treatment efficacy of different physical treatment modalities for this disorder.

Study Overview

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Baylor College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients may be eligible for this study if they:

  • Are at least 21 years old.
  • Have a diagnosis of unilateral posterior semicircular canal BPPV according to established clinical test criteria.
  • Have functional to normal range of motion of the neck and the back.

Exclusion Criteria:

Patients will not be eligible for this study if they:

  • Have a history of prior ear surgery or prior treatment for BPPV.
  • Have an orthopedic or connective tissue disorder that impairs functional neck or trunk range of motion.
  • Have a significant neurological disorder or spinal cord damage.
  • Are on vestibular suppressant medications.
  • Have Meniere's disease or acoustic neuromas.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Canalith repositioning maneuver
Repositioning treatment for posterior canal BPPV
Standard passive motion of the head: Dix-Hallpike maneuver, turn head to opposite side, roll over, sit up.
Other Names:
  • CRP
  • Epley maneuver
Experimental: Modified Epley maneuver
Head shaking exercises in pitch, roll, yaw and circumduction. Titrating from 2 repetitions per exercise to 20 repetitions per exercise, as tolerated.
Sham Comparator: Sham
The subject sat in a chair; the head was passively tilted downward, turned away from the involved side, turned back to center, upward, away from the involved side, twice, slowly.
Passive movement of the head
Active Comparator: Liberatory maneuver
The standard liberatory maneuver (also known as the Semont maneuver) was used.
Sidelying maneuver, flip over 180 deg, sit up.
Other Names:
  • Liberatory maneuver
Active Comparator: Brandt Daroff exercise
Modified Brandt Daroff exercise performed as a self-liberatory exercise.
Active exercise. Sidelying to involved side, sidelying to uninvolved side, sit up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Vertigo
Time Frame: 6 month s
6 month s

Secondary Outcome Measures

Outcome Measure
Time Frame
Balance
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Helen Cohen, EdD, Baylor College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 1998

Primary Completion (Actual)

June 1, 2003

Study Completion (Actual)

June 1, 2003

Study Registration Dates

First Submitted

November 2, 1999

First Submitted That Met QC Criteria

November 2, 1999

First Posted (Estimate)

November 3, 1999

Study Record Updates

Last Update Posted (Estimate)

July 26, 2012

Last Update Submitted That Met QC Criteria

July 25, 2012

Last Verified

July 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • NIDCD-1156
  • R01DC003602 (U.S. NIH Grant/Contract)
  • 1R01DC003602-01A1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vertigo

Clinical Trials on Canalith repositioning maneuver (Epley maneuver)

Subscribe